Riassunto
La trasfusione di componenti del sangue costituisce un presidio terapeutico insostituibile, spesso salvavita, in molte condizioni patologiche, sia in ambito medico che in ambito chirurgico. La terapia trasfusionale, principalmente praticata in pazienti critici o affetti da malattie onco-ematologiche, deve essere efficace, sicura e garantita in modo qualitativamente efficiente.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Bibliografia
Velati C, Romanò L, Fomiatti L et al for the SIMTI Research Group (2008) Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 48:2205–2213
Stramer SL, Hollinger FB, Katz LM et al (2009) Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 49:1S–29S
Gallagher LM, Ganz PR, Yang H et al (2012) Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop. Transfusion, doi:10.1111/j.1537-2995.2012.03808.x. [Epub ahead of print]
European Directorate for the Quality of Medicines and Health Care (2011) Guide to the preparation, use and quality assurance of blood components. Reccommendation n. R(95)15, 16th edn
SHOT (2009) Definitions of current SHOT categories and what to report. http://www.shotuk. org/wp-content/uploads/2010/4SHOT-Categories-2009.pdf, accesso 5 dicembre 2012
Grazzini G, Pupella S (2012) Setting and implementation of the national hemovigilance system in Italy. In: De Vries RR, Faber JC (eds) Hemovigilance. Wiley-Blackwell, Chichester, pp 204–208
ISBT (2011) Proposed standard definition for surveillance of non-infectious adverse transfusion reactions. http://www.isbtweb.org/fileadmin/user_upload/WP, accesso 5 dicembre 2012
Williamson LM (2002) Using haemovigilance data to set blood safety priorities. Vox Sanguis 8(Suppl 1):65–69
De Vries RR (2009) Haemovigilance: recent achievements and developments in the near future. ISBT Science Series 4:60–62
Ministero della salute (2011) Protocollo di monitoraggio degli eventi sentinella, 3o rapporto (settembre 2005-dicembre 2010). Dipartimento della qualità, Direzione generale della programmazione sanitaria, dei livelli di assistenza e dei principi etici di sistema, Ufficio III. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1642_allegato.pdf, accesso 5 dicembre 2012
Tinegate H, Birchall J, Gray A et al (2012) Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol 159:143–153
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Grazzini, G., Pupella, S., Facco, G. (2013). Il sistema trasfusionale. In: Tartaglia, R., Vannucci, A. (eds) Prevenire gli eventi avversi nella pratica clinica. Springer, Milano. https://doi.org/10.1007/978-88-470-5450-9_20
Download citation
DOI: https://doi.org/10.1007/978-88-470-5450-9_20
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5449-3
Online ISBN: 978-88-470-5450-9
eBook Packages: MedicineMedicine (R0)